Hamilton Thorne Ltd. (CVE:HTL – Get Free Report) shares shot up 4.3% during trading on Tuesday. The company traded as high as C$1.45 and last traded at C$1.45. 25,700 shares traded hands during mid-day trading, a decline of 27% from the average session volume of 35,118 shares. The stock had previously closed at C$1.39.
Hamilton Thorne Trading Up 4.3%
The company has a market cap of C$149.69 million, a P/E ratio of 58.94 and a beta of 0.54. The company has a quick ratio of 2.25, a current ratio of 2.04 and a debt-to-equity ratio of 43.24. The business has a 50-day moving average price of C$1.45 and a two-hundred day moving average price of C$1.45.
Hamilton Thorne Company Profile
Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. It offers precision laser systems, imaging systems, and other equipment and consumables for the ART and developmental biology research markets. The company also provides test laboratory and endotoxin testing services, as well as sperm assays, including Sperm Motility Index and Sperm Penetration; and fresh and cryopreserved mouse embryos supply, and technician training and proficiency testing services.
Recommended Stories
- Five stocks we like better than Hamilton Thorne
- Everyone in AI Is Quietly Copying Palantir’s Playbook
- Advanced Micro Devices Is Spending $8.2 Billion to Learn What AI Needs Next
- JPMorgan Bets on Genius Sports as the Market Loses Patience
- Appleās $5.7 Billion Patent Verdict Raises a Bigger Royalty Question
Receive News & Ratings for Hamilton Thorne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hamilton Thorne and related companies with MarketBeat.com's FREE daily email newsletter.
